RecallDepth
Class III Terminated

Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-01 Not for resale. Office use only. Lot: 23APR018 Date Compounded: 24APR2023 Expires on: 17APR2024. In case of adverse event contact: www.fda.gov/medwatch or (800)-FDA-1088 Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852 (844) 446-6979

Company
Imprimis Njof, Llc
Recall Initiated
October 3, 2023
Posted
October 11, 2023
Recall Number
D-0040-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
364 bags (1 mL filled in 2 mL glass amber vials; 20 vials shipped in a bag)
Firm Location
Ledgewood, NJ, United States

Reason for Recall

Subpotent: Failing Test Results for Epinephrine

Distribution

Nationwide

Lot / Code Info

23APR018

More recalls by Imprimis Njof, Llc

View all recalls by this company →

Other recent Class III Drug recalls